Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$22.92 - $33.76 $6,876 - $10,128
300 Added 0.71%
42,599 $999,000
Q4 2022

Feb 09, 2023

BUY
$25.44 - $59.78 $13,737 - $32,281
540 Added 1.29%
42,299 $1.15 Million
Q3 2022

Nov 08, 2022

BUY
$43.66 - $61.0 $23,576 - $32,940
540 Added 1.31%
41,759 $2.25 Million
Q2 2022

Aug 02, 2022

BUY
$28.82 - $77.35 $234,421 - $629,164
8,134 Added 24.59%
41,219 $1.66 Million
Q1 2022

May 10, 2022

SELL
$48.25 - $100.49 $55,970 - $116,568
-1,160 Reduced 3.39%
33,085 $2.19 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $45,064 - $61,178
508 Added 1.51%
34,245 $3.43 Million
Q3 2021

Nov 03, 2021

BUY
$98.77 - $132.17 $107,560 - $143,933
1,089 Added 3.34%
33,737 $4.22 Million
Q2 2021

Aug 13, 2021

SELL
$109.77 - $165.68 $301,867 - $455,620
-2,750 Reduced 7.77%
32,648 $4.06 Million
Q1 2021

May 03, 2021

SELL
$127.04 - $179.1 $88,928 - $125,370
-700 Reduced 1.94%
35,398 $5.4 Million
Q4 2020

Feb 02, 2021

BUY
$99.96 - $135.93 $854,458 - $1.16 Million
8,548 Added 31.03%
36,098 $4.65 Million
Q3 2020

Nov 04, 2020

BUY
$80.32 - $111.8 $22,489 - $31,304
280 Added 1.03%
27,550 $3.08 Million
Q2 2020

Aug 07, 2020

BUY
$60.49 - $97.5 $727,089 - $1.17 Million
12,020 Added 78.82%
27,270 $2.21 Million
Q1 2020

May 13, 2020

BUY
$59.04 - $88.81 $374,313 - $563,055
6,340 Added 71.16%
15,250 $1.06 Million
Q4 2019

Feb 12, 2020

BUY
$59.49 - $82.78 $9,518 - $13,244
160 Added 1.83%
8,910 $696,000
Q3 2019

Nov 07, 2019

SELL
$62.59 - $110.3 $313,575 - $552,603
-5,010 Reduced 36.41%
8,750 $559,000
Q2 2019

Aug 23, 2019

BUY
$63.94 - $91.11 $879,814 - $1.25 Million
13,760 New
13,760 $1.19 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.14B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.